NCT07463482

Brief Summary

This randomized clinical trial compares two different preoperative doses of oral paracetamol (acetaminophen) in children undergoing elective tonsillectomy. The aim is to determine whether a higher loading dose (30 mg/kg) decreases the need for opioid rescue medication after surgery compared with the standard dose (15 mg/kg), when used as part of a multimodal pain management approach. Children aged 3 to 15 years will be randomly assigned to receive either 30 mg/kg or 15 mg/kg of oral paracetamol before surgery. All participants will receive the same standard anesthesia and postoperative pain management. The primary outcome is the total amount of rescue opioid (fentanyl) required during the first 12 hours after surgery. Secondary outcomes include postoperative pain scores and the occurrence of side effects such as nausea and vomiting. This study seeks to determine whether a higher initial dose of paracetamol offers additional clinical benefits in pediatric tonsillectomy with multimodal analgesia.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Mar 2026Nov 2026

Study Start

First participant enrolled

March 1, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

March 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 11, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

March 5, 2026

Last Update Submit

March 5, 2026

Conditions

Keywords

paracetamolacetaminophentonsillectomypostoperative analgesiapediatric anesthesiamultimodal analgesia

Outcome Measures

Primary Outcomes (1)

  • Total postoperative opioid consumption

    Total postoperative opioid consumption (expressed as cumulative IV fentanyl dose in mcg/kg) was administered.

    0-12 hours after surgery

Study Arms (2)

High-dose oral paracetamol (30 mg/kg)

EXPERIMENTAL

Participants receive oral paracetamol 30 mg/kg approximately 30-60 minutes before surgery.

Drug: Paracetamol (acetaminophen)

Standard-dose oral paracetamol (15 mg/kg)

ACTIVE COMPARATOR

Participants receive oral paracetamol 15 mg/kg approximately 30-60 minutes before surgery.

Drug: Paracetamol (acetaminophen)

Interventions

Oral paracetamol administered preoperatively as a single dose ( 15 mg/kg or 30 mg/kg, depending on assigned arm).

High-dose oral paracetamol (30 mg/kg)Standard-dose oral paracetamol (15 mg/kg)

Eligibility Criteria

Age3 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 3 to 15 years
  • ASA physical status I-III
  • Scheduled for elective tonsillectomy with or without adenoidectomy

You may not qualify if:

  • Known allergy or contraindication to paracetamol or any agents in the study protocol
  • Chronic opioid use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thammasat University

Pathum Thani, Changwat Pathum Thani, 12120, Thailand

Location

MeSH Terms

Interventions

Acetaminophen

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Central Study Contacts

Waranya Lertpaitoonpan, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Faculty of Medicine, Thammasat University

Study Record Dates

First Submitted

March 5, 2026

First Posted

March 11, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations